Omeros (OMER) Notes Payables (2010 - 2012)

Omeros (OMER) reported Notes Payables of $6.4 million for Q3 2012, up 20.82% on a YoY basis from $5.3 million in Q4 2011, and up 2.62% sequentially from $6.2 million in Q2 2012.

Omeros (OMER) Notes Payables (2010 - 2012) Analysis & Trends

Omeros (OMER) has 3 years of Notes Payables data on file, last reported at $6.4 million in Q3 2012.

  • For the quarter ending Q3 2012, Notes Payables rose 20.82% year-over-year to $6.4 million; the trailing twelve-month figure through Sep 2012 stood at $6.4 million (up 20.82% YoY), and the FY2011 full-year result was $5.9 million, up 1392.41% from the prior year.
  • Notes Payables improved to $6.4 million in Q3 2012, from $6.2 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $6.4 million in Q3 2012 to a low of $395000.0 in Q4 2010.
  • A 3-year average of $4.8 million and a median of $5.9 million in 2011 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables soared 1392.41% in 2011 and advanced 20.82% in 2012, its largest moves.
  • Tracing OMER's Notes Payables over 3 years: stood at $395000.0 in 2010, then soared by 1392.41% to $5.9 million in 2011, then advanced by 8.11% to $6.4 million in 2012.
  • Business Quant data shows OMER's Notes Payables at $6.4 million in Q3 2012, $6.2 million in Q2 2012, and $6.0 million in Q1 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Sep 30, 2012 6.37 Mn
Jun 30, 2012 6.21 Mn
Mar 31, 2012 6.05 Mn
Dec 31, 2011 5.90 Mn
Sep 30, 2011 5.28 Mn
Jun 30, 2011 3.72 Mn
Dec 31, 2010 395,000.00